{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:47:13Z","timestamp":1793638033580,"version":"4.5.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Asymptomatic microscopic hematuria is an important clinical sign of urinary tract malignancy. Asymptomatic microscopic hematuria has been variably defined over the years. In addition, the evidence primarily is based on data from male patients. However, whether the patient is a man or a woman influences the differential diagnosis of asymptomatic microscopic hematuria, and the risk of urinary tract malignancy (bladder, ureter, and kidney) is significantly less in women than in men. Among women, being older than 60 years, having a history of smoking, and having gross hematuria are the strongest predictors of urologic cancer. In low-risk, never-smoking women younger than 50 years without gross hematuria and with fewer than 25 red blood cells per high-power field, the risk of urinary tract malignancy is less than or equal to 0.5%. Furthermore, the evaluation may result in more harm than benefit and is unlikely to be cost effective. Thus, data support changing current hematuria recommendations in this low-risk group. The American College of Obstetricians and Gynecologists and the American Urogynecologic Society encourage organizations producing future guidelines on the evaluation of microscopic hematuria to perform sex-specific analysis of the data and produce practical sex-specific recommendations. In the meantime, the American College of Obstetricians and Gynecologists and the American Urogynecologic Society recommend that asymptomatic, low-risk, never-smoking women aged 35\u201350 years undergo evaluation only if they have more than 25 red blood cells per high-power field.<\/jats:p>","DOI":"10.1097\/aog.0000000000002059","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T14:30:31Z","timestamp":1491057031000},"page":"e168-e172","source":"Crossref","is-referenced-by-count":19,"title":["Committee Opinion No.703: Asymptomatic Microscopic Hematuria in Women"],"prefix":"10.1097","volume":"129","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0090-4295(01)00920-7","article-title":"Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy\u2013part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up","volume":"57","author":"Grossfeld","year":"2001","journal-title":"Urology"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0090-4295(01)00919-0","article-title":"Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy\u2013part I: definition, detection, prevalence, and etiology","volume":"57","author":"Grossfeld","year":"2001","journal-title":"Urology"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"246","DOI":"10.7326\/0003-4819-155-4-201108160-00008","article-title":"Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement [published erratum appears in Ann Intern Med 2011;155:408]","volume":"155","author":"Moyer","year":"2011","journal-title":"Ann Intern Med"},{"issue":"146","key":"R5-20230711","first-page":"e1","article-title":"Evaluation of microscopic hematuria and risk of urologic cancer in female patients","volume":"216","author":"Lippmann","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"67","key":"R6-20230711","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics","volume":"2017","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-5347(17)39379-5","article-title":"Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients","volume":"144","author":"Murakami","year":"1990","journal-title":"J Urol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s001920050060","article-title":"Asymptomatic microscopic hematuria in women: case series and brief review","volume":"10","author":"Singh","year":"1999","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1001\/archinte.1988.00380120083017","article-title":"The significance of asymptomatic microhematuria in women and its economic implications. A ten-year study","volume":"148","author":"Bard","year":"1988","journal-title":"Arch Intern Med"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00345-007-0228-x","article-title":"Immunocytology in the assessment of patients with asymptomatic hematuria","volume":"26","author":"Schmitz-Drager","year":"2008","journal-title":"World J Urol"},{"key":"R11-20230711","first-page":"281","article-title":"A long-term follow-up study of asymptomatic hematuria and\/or proteinuria in adults","volume":"45","author":"Yamagata","year":"1996","journal-title":"Clin Nephrol"},{"key":"R12-20230711","first-page":"413","article-title":"Etiology of asymptomatic microscopic hematuria in adults","volume":"39","author":"Yamamoto","year":"1993","journal-title":"Hinyokika Kiyo"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02768236","article-title":"Clinical study of asymptomatic microscopic haematuria","volume":"26","author":"Yasumasu","year":"1994","journal-title":"Int Urol Nephrol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-5347(17)38331-3","article-title":"Long-term followup of asymptomatic microhematuria","volume":"145","author":"Howard","year":"1991","journal-title":"J Urol"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.eururo.2006.10.046","article-title":"Immunocytology in the assessment of patients with asymptomatic microhaematuria","volume":"51","author":"Schmitz-Drager","year":"2007","journal-title":"Eur Urol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.juro.2010.12.093","article-title":"Association of hematuria on microscopic urinalysis and risk of urinary tract cancer","volume":"185","author":"Jung","year":"2011","journal-title":"J Urol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(01)63529-8","article-title":"Evaluation and management of solid and cystic renal masses","volume":"159","author":"Wolf","year":"1998","journal-title":"J Urol"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1464-4096.2001.01899.x","article-title":"The community-based morbidity of flexible cystoscopy","volume":"89","author":"Burke","year":"2002","journal-title":"BJU Int"},{"key":"R21-20230711","first-page":"51","article-title":"Contrast-induced nephropathy; a literature review","volume":"3","author":"Golshahi","year":"2014","journal-title":"J Nephropathol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography\u2014an increasing source of radiation exposure","volume":"357","author":"Brenner","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urolonc.2008.10.018","article-title":"Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey","volume":"28","author":"Nieder","year":"2010","journal-title":"Urol Oncol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"633,640","DOI":"10.1016\/j.amjmed.2014.01.010","article-title":"Variation in the intensity of hematuria evaluation: a target for primary care quality improvement","volume":"127","author":"Friedlander","year":"2014","journal-title":"Am J Med"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.urolonc.2012.07.001","article-title":"What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up","volume":"32","author":"Buteau","year":"2014","journal-title":"Urol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201706000-00051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T18:20:04Z","timestamp":1689099604000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201706000-00051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002059","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}